TG Therapeutics Inc (TGTX)

Debt-to-assets ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	100,118	71,135	66,788	7,716	28,970
Total assets	US$ in thousands	329,587	193,572	379,629	625,642	163,014
Debt-to-assets ratio		0.30	0.37	0.18	0.01	0.18

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $100,118K ÷ $329,587K
= 0.30

The debt-to-assets ratio of TG Therapeutics Inc has fluctuated over the past five years. In 2023, the ratio stood at 0.30, indicating that 30% of the company's assets are funded by debt. This is a decrease from the previous year, 2022, where the ratio was 0.37. The company's debt-to-assets ratio was significantly higher in 2022 compared to 2021 when it was at 0.18. The ratio was also notably higher in 2020 at 0.01, suggesting a very low level of debt relative to assets. However, in 2019, the ratio was comparable to 2021 at 0.18.

The trend in the debt-to-assets ratio indicates that TG Therapeutics Inc has been managing its debt levels relative to its asset base, with fluctuations seen in recent years. A lower debt-to-assets ratio generally indicates lower financial risk as the company relies less on debt financing. Conversely, a higher ratio could suggest a higher level of financial risk due to increased reliance on debt to fund operations and growth.